Wickliffe Pharmaceutical Inc – FDA 483, May 22, 2014
This FDA Form 483 document details inspectional observations made at Wickliffe Pharmaceutical Inc., a compounding pharmacy located at 4340 Georgetown Rd., Lexington, KY 40511. The inspection was conducted on April 29-30, 2014, and May 9, 14, 22, 2014, by Kathleen Dant Culver, Investigator/Drug Preapproval Manager. The report is issued to Jacqueline S. Bernard, President and Owner.
Two key observations relate to the potency of compounded drug products:
1. **Lot 28-03-2014@44 (BUD 9/24/2014) of toltrazuril and pyrimethamine suspension**, labeled to contain 416 mg/ml toltrazuril and 17 mg/ml pyrimethamine, and dispensed under Rx #294545, showed significant deviations: * Pyrimethamine was found at 405 +/- 69 mg/ml, which is 2380% of the declared potency. * Toltrazuril was found at 15.5 +/- 2.5 mg/ml, which is 3.74% of the declared potency.
2. **Lot 25-03-20
ID · dc5e4f53-ae59-4796-a3bf-5052bac8a61b
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.